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Letter to the Editor
With interest we read the article by Billing-Ross et al. 
[1] about 193 patients with chronic fatigue syndrome 
(CFS) diagnosed according to the Fukuda or Canadian 
Consensus criteria and undergoing sequencing of the 
mtDNA, the DePaul Symptom questionnaire and the 
Medical Outcome Survey Short Form-36. The study 
showed that CFS is associated with mtDNA haplogroups 
J, U and H, that 8 mtDNA single nucleotide polymor-
phisms (SNPs) were associated with 16 symptom cat-
egories, and that three haplogroups were associated with 
six symptom categories [1]. We have the following com-
ments and concerns.
The main limitation of this study is that only the 
mtDNA was investigated for sequence variants. Since it 
is well-known that mitochondrial disorders (MIDs) may 
be also caused by mutations in nDNA-located genes, 
particularly in children [2], disease-causing mutations 
or SNPs facilitating the development of CFS may have 
been missed. Furthermore, MIDs may not only be due 
to respiratory chain dysfunction but also due to disrup-
tion of other mitochondrial pathways, such as the beta-
oxidation, the hem synthesis, the calcium handling, the 
coenzyme-Q metabolism, or the urea cycle. There is 
also consensus that investigations of mtDNA mutations 
or SNPs in mtDNA from lymphocytes may not be con-
structive since some mutations may not be present or 
heteroplasmy rates may be lower than in more severely 
affected tissues [3].
A further limitation of the study is that neither 
immune-histological nor biochemical investigations of 
the muscle biopsy were carried out. Immune-histological 
investigations of the muscle biopsy may show NADH-, 
SDH-, or COX-deficiency. Biochemical investigations of 
the muscle homogenate may show reduced activity of 
one or several respiratory chain complexes or coenzyme-
Q deficiency [4]. Morphological and functional studies 
are essential not to miss dysfunction of the respiratory 
chain or other mitochondrial pathways.
We also should be informed how causes of fatigue, 
exhaustion, and exercise intolerance other than CFS, 
were excluded. How many patients had muscle disease 
other than a MID, which may be also associated with 
fatigue, such as muscular dystrophies or congenital myo-
pathies [5, 6]? How many had hypothyroidism, sleep 
apnea syndrome, malignancy, electrolyte disturbances, 
adrenal dysfunction, or pituitary insufficiency? Were 
any of the routine laboratory parameters abnormal in 
the 193 patients? How many had creatine-kinase (CK) 
elevation or lactacidosis? How many presented with fea-
tures other than fatigue which could be attributed to a 
MID? How many had epilepsy, cognitive impairment, 
extra-pyramidal disease, or psychiatric disease? How 
many had a cataract, glaucoma, retinitis, or chronic pro-
gressive external ophthalmoplegia (CPEO)? It would 
be interesting to known if any of the patients had car-
diac disease, gastrointestinal disease, renal impairment, 
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Nothing is reported about the previous history of the 
197 patients and their permanent medication [1]. How 
often was the family history positive for CFS or a MID?
Overall, this interesting study may profit from provid-
ing more information about the individual patients and 
their relatives and from carrying out more comprehen-
sive morphological, functional, and genetic studies not 
to miss metabolic defects, which may be due to sequence 
variations in nDNA located mitochondrial genes. There 
is also a need to exclude cardiac, pulmonary, or systemic 
disease not to miss differentials of CSF.
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